✦ LIBER ✦

Local Recurrence Rates are Low in High-Risk Neoadjuvant Breast Cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657)

✍ Scribed by Cureton, Elizabeth L.; Yau, Christina; Alvarado, Michael D.; Krontiras, Helen; Ollila, David W.; Ewing, Cheryl A.; Monnier, Sindy; Esserman, Laura J.

Book ID: 125406084
Publisher: Springer
Year: 2014
Tongue: English
Weight: 331 KB
Volume: 21
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-014-3721-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy response and recurrence-fre

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

✍ Laura J. Esserman; Donald A. Berry; Maggie C. U. Cheang; Christina Yau; Charles 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 788 KB

Locally advanced breast cancers are more

Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial)

✍ Cheryl Lin; Meredith Becker Buxton; Dan Moore; Helen Krontiras; Lisa Carey; Ange 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 404 KB

Clinically Meaningful Tumor Reduction Ra

Clinically Meaningful Tumor Reduction Rates Vary by Prechemotherapy MRI Phenotype and Tumor Subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

✍ Mukhtar, Rita A.; Yau, Christina; Rosen, Mark; Tandon, Vickram J.; Hylton, Nola; 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 692 KB